184 related articles for article (PubMed ID: 20508670)
41. Mildly Acidic pH Triggers an Irreversible Conformational Change in the Fusion Domain of Herpes Simplex Virus 1 Glycoprotein B and Inactivation of Viral Entry.
Weed DJ; Pritchard SM; Gonzalez F; Aguilar HC; Nicola AV
J Virol; 2017 Mar; 91(5):. PubMed ID: 28003487
[TBL] [Abstract][Full Text] [Related]
42. Antibody-mediated targeted gene transfer to NMDA NR1-containing neurons in rat neocortex by helper virus-free HSV-1 vector particles containing a chimeric HSV-1 glycoprotein C-staphylococcus A protein.
Cao H; Zhang GR; Geller AI
Brain Res; 2010 Sep; 1351():1-12. PubMed ID: 20599821
[TBL] [Abstract][Full Text] [Related]
43. Simultaneous Insertion of Two Ligands in gD for Cultivation of Oncolytic Herpes Simplex Viruses in Noncancer Cells and Retargeting to Cancer Receptors.
Leoni V; Petrovic B; Gianni T; Gatta V; Campadelli-Fiume G
J Virol; 2018 Mar; 92(6):. PubMed ID: 29263255
[TBL] [Abstract][Full Text] [Related]
44. Basic amino acids as modulators of an O-linked glycosylation signal of the herpes simplex virus type 1 glycoprotein gC: functional roles in viral infectivity.
Mårdberg K; Nyström K; Tarp MA; Trybala E; Clausen H; Bergström T; Olofsson S
Glycobiology; 2004 Jul; 14(7):571-81. PubMed ID: 15044392
[TBL] [Abstract][Full Text] [Related]
45. Neomycin inhibits glycoprotein C (gC)-dependent binding of herpes simplex virus type 1 to cells and also inhibits postbinding events in entry.
Herold BC; Spear PG
Virology; 1994 Aug; 203(1):166-71. PubMed ID: 8030274
[TBL] [Abstract][Full Text] [Related]
46. Characterization of herpes simplex virus type 1 recombinants that express and incorporate high levels of HCV E2-gC chimeric proteins.
Kouvatsis V; Argnani R; Tsitoura E; Arsenakis M; Georgopoulou U; Mavromara P; Manservigi R
Virus Res; 2007 Jan; 123(1):40-9. PubMed ID: 16989918
[TBL] [Abstract][Full Text] [Related]
47. Characterization of a recombinant herpes simplex virus 1 designed to enter cells via the IL13Ralpha2 receptor of malignant glioma cells.
Zhou G; Roizman B
J Virol; 2005 May; 79(9):5272-7. PubMed ID: 15827141
[TBL] [Abstract][Full Text] [Related]
48. Sialic acid on herpes simplex virus type 1 envelope glycoproteins is required for efficient infection of cells.
Teuton JR; Brandt CR
J Virol; 2007 Apr; 81(8):3731-9. PubMed ID: 17229687
[TBL] [Abstract][Full Text] [Related]
49. A small molecule inhibits virion attachment to heparan sulfate- or sialic acid-containing glycans.
Colpitts CC; Schang LM
J Virol; 2014 Jul; 88(14):7806-17. PubMed ID: 24789779
[TBL] [Abstract][Full Text] [Related]
50. HSV/AAV hybrid amplicon vectors extend transgene expression in human glioma cells.
Johnston KM; Jacoby D; Pechan PA; Fraefel C; Borghesani P; Schuback D; Dunn RJ; Smith FI; Breakefield XO
Hum Gene Ther; 1997 Feb; 8(3):359-70. PubMed ID: 9048203
[TBL] [Abstract][Full Text] [Related]
51. Specific targeted binding of herpes simplex virus type 1 to hepatocytes via the human hepatitis B virus preS1 peptide.
Argnani R; Boccafogli L; Marconi PC; Manservigi R
Gene Ther; 2004 Jul; 11(13):1087-98. PubMed ID: 15057264
[TBL] [Abstract][Full Text] [Related]
52. Herpes simplex virus type 1 glycoprotein K is not essential for infectious virus production in actively replicating cells but is required for efficient envelopment and translocation of infectious virions from the cytoplasm to the extracellular space.
Jayachandra S; Baghian A; Kousoulas KG
J Virol; 1997 Jul; 71(7):5012-24. PubMed ID: 9188566
[TBL] [Abstract][Full Text] [Related]
53. Localization of a functional site on herpes simplex virus type 1 glycoprotein C involved in binding to cell surface heparan sulphate.
Trybala E; Bergström T; Svennerholm B; Jeansson S; Glorioso JC; Olofsson S
J Gen Virol; 1994 Apr; 75 ( Pt 4)():743-52. PubMed ID: 7512117
[TBL] [Abstract][Full Text] [Related]
54. Heparanase is a host enzyme required for herpes simplex virus-1 release from cells.
Hadigal SR; Agelidis AM; Karasneh GA; Antoine TE; Yakoub AM; Ramani VC; Djalilian AR; Sanderson RD; Shukla D
Nat Commun; 2015 Apr; 6():6985. PubMed ID: 25912399
[TBL] [Abstract][Full Text] [Related]
55. An enhanced packaging system for helper-dependent herpes simplex virus vectors.
Stavropoulos TA; Strathdee CA
J Virol; 1998 Sep; 72(9):7137-43. PubMed ID: 9696807
[TBL] [Abstract][Full Text] [Related]
56. The role of a single N-linked glycosylation site for a functional epitope of herpes simplex virus type 1 envelope glycoprotein gC.
Olofsson S; Bolmstedt A; Biller M; Mårdberg K; Leckner J; Malmström BG; Trybala E; Bergström T
Glycobiology; 1999 Jan; 9(1):73-81. PubMed ID: 9884409
[TBL] [Abstract][Full Text] [Related]
57. Monoclonal antibodies to distinct sites on herpes simplex virus (HSV) glycoprotein D block HSV binding to HVEM.
Nicola AV; Ponce de Leon M; Xu R; Hou W; Whitbeck JC; Krummenacher C; Montgomery RI; Spear PG; Eisenberg RJ; Cohen GH
J Virol; 1998 May; 72(5):3595-601. PubMed ID: 9557640
[TBL] [Abstract][Full Text] [Related]
58. Development of an oncolytic HSV vector fully retargeted specifically to cellular EpCAM for virus entry and cell-to-cell spread.
Shibata T; Uchida H; Shiroyama T; Okubo Y; Suzuki T; Ikeda H; Yamaguchi M; Miyagawa Y; Fukuhara T; Cohen JB; Glorioso JC; Watabe T; Hamada H; Tahara H
Gene Ther; 2016 Jun; 23(6):479-88. PubMed ID: 26905369
[TBL] [Abstract][Full Text] [Related]
59. Replication-Competent Controlled Herpes Simplex Virus.
Bloom DC; Feller J; McAnany P; Vilaboa N; Voellmy R
J Virol; 2015 Oct; 89(20):10668-79. PubMed ID: 26269179
[TBL] [Abstract][Full Text] [Related]
60. Oncolytic herpes simplex virus vector with enhanced MHC class I presentation and tumor cell killing.
Todo T; Martuza RL; Rabkin SD; Johnson PA
Proc Natl Acad Sci U S A; 2001 May; 98(11):6396-401. PubMed ID: 11353831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
